ATE179211T1 - Menschliche il-3-varianten - Google Patents

Menschliche il-3-varianten

Info

Publication number
ATE179211T1
ATE179211T1 AT92921235T AT92921235T ATE179211T1 AT E179211 T1 ATE179211 T1 AT E179211T1 AT 92921235 T AT92921235 T AT 92921235T AT 92921235 T AT92921235 T AT 92921235T AT E179211 T1 ATE179211 T1 AT E179211T1
Authority
AT
Austria
Prior art keywords
pct
variants
human
sec
methods
Prior art date
Application number
AT92921235T
Other languages
English (en)
Inventor
Mathew Alexander Vadas
Angel Francisco Lopez
Mary Frances Shannon
Original Assignee
Medvet Science Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medvet Science Pty Ltd filed Critical Medvet Science Pty Ltd
Application granted granted Critical
Publication of ATE179211T1 publication Critical patent/ATE179211T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5403—IL-3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT92921235T 1991-10-07 1992-10-07 Menschliche il-3-varianten ATE179211T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPK874291 1991-10-07

Publications (1)

Publication Number Publication Date
ATE179211T1 true ATE179211T1 (de) 1999-05-15

Family

ID=3775735

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92921235T ATE179211T1 (de) 1991-10-07 1992-10-07 Menschliche il-3-varianten

Country Status (11)

Country Link
US (1) US5591427A (de)
EP (1) EP0609280B1 (de)
JP (1) JPH07501520A (de)
AT (1) ATE179211T1 (de)
AU (1) AU668364B2 (de)
CA (1) CA2120707A1 (de)
DE (1) DE69228997T2 (de)
DK (1) DK0609280T3 (de)
ES (1) ES2133329T3 (de)
GR (1) GR3030032T3 (de)
WO (1) WO1993007171A1 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6586222B1 (en) 1989-08-16 2003-07-01 Chiron Corporation Recombinant PR-3 and compositions thereof
US5843693A (en) * 1989-08-16 1998-12-01 Chiron Corporation Assay method for screening for inhibitors of proTNF conversion
US5998378A (en) * 1989-08-16 1999-12-07 Chiron Corporation Compositions for the inhibition of TNF hormone formation and uses thereof
US6361977B1 (en) * 1992-11-24 2002-03-26 S. Christopher Bauer Methods of using multivariant IL-3 hematopoiesis fusion protein
US6361976B1 (en) 1992-11-24 2002-03-26 S. Christopher Bauer Co-administration of interleukin-3 mutant polypeptides with CSF'S for multi-lineage hematopoietic cell production
US6153183A (en) * 1992-11-24 2000-11-28 G. D. Searle & Company Co-administration of interleukin-3 mutant polypeptides with CSF's or cytokines for multi-lineage hematopoietic cell production
US6413509B1 (en) * 1992-11-24 2002-07-02 S. Christopher Bauer Methods of ex-vivo expansion of hematopoietic cells using interleukin-3 mutant polypeptides with other hematopoietic growth factors
US6057133A (en) * 1992-11-24 2000-05-02 G. D. Searle Multivariant human IL-3 fusion proteins and their recombinant production
US7091319B1 (en) * 1992-11-24 2006-08-15 Bauer S Christopher IL-3 variant hematopoiesis fusion protein
US6436387B1 (en) * 1992-11-24 2002-08-20 G.D. Searle & Co. Methods of ex-vivo expansion of hematopoietic cells using multivariant IL-3 hematopoiesis chimera proteins
US6403076B1 (en) 1992-11-24 2002-06-11 S. Christopher Bauer Compositions for increasing hematopoiesis with interleukin-3 mutants
US5772992A (en) * 1992-11-24 1998-06-30 G.D. Searle & Co. Compositions for co-administration of interleukin-3 mutants and other cytokines and hematopoietic factors
EP1361273A3 (de) * 1992-11-24 2004-02-11 G.D. Searle & Co. Interleukin-3 (iL-3) mit mehrfachen mutationen Polypeptide
US5738849A (en) * 1992-11-24 1998-04-14 G. D. Searle & Co. Interleukin-3 (IL-3) variant fusion proteins, their recombinant production, and therapeutic compositions comprising them
EP0715633A4 (de) * 1993-07-28 1997-11-19 Medvet Science Pty Ltd Antagonisten des hämopoietischen wachstumsfaktor
WO1995013089A1 (en) * 1993-11-10 1995-05-18 Henry M. Jackson Foundation For The Advancement Of Military Medicine Compositions and method for stimulating antibody release by b lymphocytes
US20050059149A1 (en) * 1993-11-22 2005-03-17 Bauer S. Christopher Methods of ex-vivo expansion of hematopoeitic cells using multivariant IL-3 hematopoiesis chimera proteins
WO1995024501A1 (en) 1994-03-07 1995-09-14 Cetus Oncology Corporation Compositions for the inhibition of tnf formation and uses thereof
US6465616B1 (en) 1994-04-08 2002-10-15 Bresagen Limited Interleukin-5 antagonist
US6017523A (en) * 1995-06-06 2000-01-25 G.D. Searle & Co. Therapeutic methods employing mutant human interleukin-3 (IL-3) polypeptides
WO1997012979A1 (en) * 1995-10-05 1997-04-10 G.D Searle & Co. Interleuken-3 (il-3) receptor agonists

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
OA09736A (en) * 1987-02-18 1993-11-30 Schering Biotech Corp "Human interleukin-3 and muteins thereof".
EP0810285A3 (de) * 1989-08-14 1998-07-08 Gist-Brocades B.V. Mutanten von menschlichen Interleukin-3

Also Published As

Publication number Publication date
DE69228997D1 (de) 1999-05-27
WO1993007171A1 (en) 1993-04-15
JPH07501520A (ja) 1995-02-16
EP0609280A4 (en) 1994-09-14
GR3030032T3 (en) 1999-07-30
EP0609280A1 (de) 1994-08-10
AU668364B2 (en) 1996-05-02
EP0609280B1 (de) 1999-04-21
DK0609280T3 (da) 1999-10-25
AU2753892A (en) 1993-05-03
CA2120707A1 (en) 1993-04-15
ES2133329T3 (es) 1999-09-16
US5591427A (en) 1997-01-07
DE69228997T2 (de) 1999-08-26

Similar Documents

Publication Publication Date Title
ATE179211T1 (de) Menschliche il-3-varianten
DE69830404D1 (de) P38-inhibitoren
BR9714415A (pt) Heterociclos contendo nitrogênio substituìdo como inibidores de proteìnas quinase p38
MY132496A (en) Inhibitors of p38
MY117696A (en) INHIBITORS OF p38
ATE393831T1 (de) Zusammensetzung zur in vivo erzeugung von therapeutischen produkten
ATE218879T1 (de) Therapeutische verwendungen von bakterizide/permeabilitätserhöhende protein dimer produkte
DE69526937D1 (de) Verwendung von methanbisphosphonsäurederivaten zur behandlung von aufgelockerten prothesen
ATE169503T1 (de) Rekombinante viren und ihre verwendung bei der gentherapie
FI972308A0 (fi) 2-substituoituja 1,2,5-tiadiatsolidin-3-oni-1,1-dioksideja ja niitä sisältäviä koostumuksia ja menetelmiä niiden käyttämiseksi
DE59409735D1 (de) ALKOXYALKYLCARBAMATE VON IMIDAZO[1,2-a]PYRIDINEN
MX9805705A (es) Compuestos biaromaticos, composiciones farmaceuticas y cosmeticas que los contienen y utilizaciones.
ATE382061T1 (de) Mittel zur induktion von apoptosis und zur therapieanwendung
DE59209196D1 (de) Menschliche il-4 mutantenproteine
MX9707668A (es) Compuestos biarilicos heterociclicos, composiciones farmaceuticas y cosmeticas que los contienen y uso de las mismas.
DK0633763T3 (da) Kosmetiske eller farmaceutiske sammensætninger indeholdende deacylerede glycerophospholipider til topisk brug
DE69711078D1 (de) Topische verwendung von kappa-opioidrezeptoragonisten zur behandlung von augenschmerz
TR199901385T2 (xx) Piperidin t�revleri.
AU4872797A (en) Novel biaromatic dibenzofuran derivatives and their use in human or veterinary medicine and in cosmetics
ID23184A (id) Garam-garam peptida bpc dengan aktivitas organoprotektif proses pembuatan dan penggunaannya dalam terapi
DE69323191D1 (de) Wasserlösliche retinoide
MY129421A (en) INHIBITORS OF p38
ATE175349T1 (de) Verwendung von etofibrat und pharmazeutische zusammensetzungen, enthaltend etofibrat, zur behandlung der diabetischen angio- und retinopathie

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee